Human immunodeficiency virus type 1-anchored CD40 ligand induces secretion of the chemokine interleukin-8 by human primary macrophages

被引:10
作者
Maurais, Emilie
Cantin, Rejean
Tremblay, Michel J. [1 ]
机构
[1] CHU Laval, Ctr Rech Infectiol, Lab Immunoretrovirol Humaine, Quebec City, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
HIV; AIDS; Macrophage; Human; HUMAN LYMPHOID-TISSUE; T-CELLS; ANTIRETROVIRAL THERAPY; CCR5; EXPRESSION; HIV-INFECTION; HOST ICAM-1; PATHOGENESIS; ACTIVATION; REPLICATION; LYMPHOCYTES;
D O I
10.1016/j.virol.2008.11.033
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD40 ligand (CD40L) is mainly expressed in activated CD4(+)T cells and interacts with CD40 on antigen-presenting cells to regulate both humoral and cellular immune responses. We previously reported that CD40L is acquired by emerging HIV-1 particles. Here we demonstrate that both wild-type and a nonfunctional mutated form of CD40L are incorporated within HIV-1. Importantly, we show that wild-type CD40L remains functional since CD40L-bearing virions mediate NF-kappa B activation in a CD40-expressing reporter cell line and induce secretion of the chemokine IL-8 by monocyte-derived macrophages. These results suggest a possible means exploited by HIV-1 to attract susceptible target cells to the site of infection, a process that might promote viral dissemination. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 22 条
[1]   Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1 [J].
Beauséjour, Y ;
Tremblay, MJ .
JOURNAL OF VIROLOGY, 2004, 78 (21) :11916-11925
[2]   Increased CD4 and CCR5 expression and human immunodeficiency virus type 1 entry in CD40 ligand-stimulated macrophages [J].
Bergamini, A ;
Bolacchi, F ;
Pesce, CD ;
Carbone, M ;
Cepparulo, M ;
Demin, F ;
Rocchi, G .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (11) :1567-1577
[3]   Effect of different activation stimuli on the cytokine response of human macrophages to CD40L [J].
Bolacchi, F ;
Carbone, M ;
Capozzi, M ;
Ventura, L ;
Cepparulo, M ;
Niutta, P ;
Rocchi, G ;
Bergamini, A .
CYTOKINE, 2001, 16 (04) :121-125
[4]   Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4+-T-cell depletion in human lymphoid tissue, a major site of replication in vivo [J].
Bounou, S ;
Leclerc, JE ;
Tremblay, MJ .
JOURNAL OF VIROLOGY, 2002, 76 (03) :1004-1014
[5]   Regulation of human immunodeficiency virus type 1 infection, β-chemokine production, and CCR5 expression in CD40L-stimulated macrophages:: Immune control of viral entry [J].
Cotter, RL ;
Zheng, JL ;
Che, M ;
Niemann, D ;
Liu, Y ;
He, J ;
Thomas, E ;
Gendelman, HE .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4308-4320
[6]   Activation of monocytic cells through Fcγ receptors induces the expression of macrophage-inflammatory protein (MIP)-1α, MIP-1β, and RANTES [J].
Fernández, N ;
Renedo, M ;
García-Rodríguez, C ;
Crespo, MS .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3321-3328
[7]   Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity [J].
Fortin, JF ;
Cantin, R ;
Lamontagne, G ;
Tremblay, M .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3588-3596
[8]  
FROST SDW, 1994, J ACQ IMMUN DEF SYND, V7, P236
[9]  
KIENER PA, 1995, J IMMUNOL, V155, P4917
[10]   Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy [J].
Lane, BR ;
Lore, K ;
Bock, PJ ;
Andersson, J ;
Coffey, MJ ;
Strieter, RM ;
Markovitz, DM .
JOURNAL OF VIROLOGY, 2001, 75 (17) :8195-8202